Figure 2
From: Development of an in vitro model to test antifibrotic drugs on primary human liver myofibroblasts
Components of variability in α-SMA and Coll1 transcription levels. Overall data were first normalized to mean 0 and variance 1. Differences from the mean, taking nesting into account (ie, within patients for experiments, within experiments for PCR) were then computed. Between-patient variability accounted for ~70% of all variability, between-experiment variability for 30% and PCR repeats for <1%.
